Molim Inc

molim Inc.| Pioneering Molecular Imaging for Translational Drug Development molim Inc. is South Korea’s first and only private CRO fully specialized in molecular imaging for both preclinical and clinical-stage drug development. We empower pharmaceutical and biotech companies by providing cutting-edge radiolabeling and molecular imaging services that visualize and quantify the pharmacokinetics (PK), biodistribution, and mechanism of action (MoA) of biologics — including antibodies, extracellular vesicles (EVs), gene & cell therapies, and novel modalities. Why molim? The Only Private Molecular Imaging CRO in Korea First in Korea to offer exploratory Phase 0 clinical imaging trials Fastest time-to-data with streamlined imaging and analysis pipelines Largest molecular imaging data library in the country Proven global-standard imaging quality and regulatory-compliant expertise Our Services Radiolabeling (Antibodies, EVs, small molecules, mRNA/LNP, etc.) In vivo imaging (PET/CT, SPECT, optical) Preclinical biodistribution & PK studies Clinical molecular imaging (Phase 0/I) Data analysis & regulatory documentation Our Mission To accelerate the translation of cutting-edge biotherapeutics from bench to bedside, by delivering quantitative, visual, and regulatory-grade evidence through molecular imaging.